Table 1 Baseline characteristics of participants in NHANES 2003–2010.
From: Association between inflammation indicators and albuminuria in US adults: a cross-sectional study
Characteristic | Overall N = 18,876 | Non-Albuminuria N = 16,555 | Albuminuria N = 2,321 | p-value |
|---|---|---|---|---|
Age, Median (IQR) | 49.00 (35.00–65.00) | 48.00 (34.00–63.00) | 64.00 (47.00–76.00) | < 0.001 |
Gender, n (%) | 0.68 | |||
Male | 9,465 (50.14) | 8,292 (50.09) | 1,173 (50.54) | |
Female | 9,411 (49.86) | 8,263 (49.91) | 1,148 (49.46) | |
Race, n (%) | < 0.001 | |||
Mexican American | 3,549 (18.80) | 3,074 (18.57) | 475 (20.47) | |
Other Hispanic | 1,399 (7.41) | 1,235 (7.46) | 164 (7.07) | |
No- Hispanic White | 9,462 (50.13) | 8,397 (50.72) | 1,065 (45.89) | |
No- Hispanic Black | 3,619 (19.17) | 3,116 (18.82) | 503 (21.67) | |
Other Race | 847 (4.49) | 733 (4.43) | 114 (4.91) | |
Education Level, n (%) | < 0.001 | |||
Less than high school | 5,464 (28.98) | 4,551 (27.52) | 913 (39.35) | |
High school or GED | 4,533 (24.04) | 4,004 (24.21) | 529 (22.80) | |
Above high school | 8,860 (46.99) | 7,982 (48.27) | 878 (37.84) | |
PIR, n (%) | < 0.001 | |||
< 1.3 | 5,232 (29.87) | 4,465 (29.03) | 767 (35.96) | |
1.3–3.5 | 6,808 (38.87) | 5,911 (38.43) | 897 (42.05) | |
> 3.5 | 5,476 (31.26) | 5,007 (32.55) | 469 (21.99) | |
BMI, n (%) | < 0.001 | |||
Underweight | 283 (1.52) | 230 (1.40) | 53 (2.34) | |
Normal weight | 5,233 (28.03) | 4,673 (28.48) | 560 (24.77) | |
Overweight | 6,467 (34.64) | 5,785 (35.26) | 682 (30.16) | |
Obesity | 6,684 (35.81) | 5,718 (34.85) | 966 (42.72) | |
Smoking Status, n (%) | < 0.001 | |||
No | 9,765 (51.76) | 8,669 (52.36) | 1,096 (47.22) | |
Yes | 9,101 (48.24) | 7,877 (47.61) | 1,224 (52.76) | |
Drinking Status, n (%) | < 0.001 | |||
Never | 2,357 (13.52) | 1,991 (13.00) | 366 (17.26) | |
Mild | 5,540 (31.78) | 4,961 (32.40) | 579 (27.30) | |
Moderate | 3,697 (21.21) | 3,395 (22.17) | 302 (14.24) | |
Heavy | 2,257 (12.95) | 2,042 (13.34) | 215 (10.14) | |
Former | 3,581 (20.54) | 2,922 (19.08) | 659 (31.07) | |
Diabetes, n (%) | < 0.001 | |||
No | 15,925 (84.37) | 14,526 (87.74) | 1,399 (60.28) | |
Yes | 2,951 (15.63) | 2,029 (12.26) | 922 (39.72) | |
Hypertension, n (%) | < 0.001 | |||
No | 10,914 (57.85) | 10,196 (61.61) | 718 (30.96) | |
Yes | 7,955 (42.16) | 6,354 (38.39) | 1,601 (69.04) | |
Albumin(g/dL), Median (IQR) | 4.20 (4.00–4.40) | 4.30 (4.00–4.50) | 4.10 (3.90–4.40) | < 0.001 |
Serum uric acid(mg/dL), Median (IQR) | 5.40 (4.50–6.40) | 5.30 (4.40–6.30) | 5.70 (4.70–6.80) | < 0.001 |
TC (mg/dL), Median (IQR) | 194.00 (168.00–223.00) | 194.00 (169.00–223.00) | 192.00 (164.00–222.00) | 0.012 |
HDL-C(mg/dL), Median (IQR) | 50.00 (41.00–62.00) | 51.00 (42.00–62.00) | 49.00 (40.00–61.00) | < 0.001 |
AST(U/L), Median (IQR) | 23.00 (20.00–28.00) | 23.00 (20.00–28.00) | 23.00 (20.00–29.00) | 0.13 |
ALT(U/L), Median (IQR) | 21.00 (17.00–29.00) | 21.00 (17.00–29.00) | 20.00 (16.00–27.00) | < 0.001 |
eGFR(mL/min/1.73m2), Median (IQR) | 93.81 (76.78–109.40) | 95.15 (78.96–110.18) | 80.87 (58.53–100.80) | < 0.001 |
